Coronary atherosclerotic heart disease (CAHD) can be clinically classified as stable angina pectoris (SAP), unstable angina pectoris (UAP), and myocardial infarction (MI), the pathogenesis of which includes endothelial damage, inflammation, oxidative stress, plaque rupture, and thrombosis. Western medicine, percutaneous coronary intervention and coronary artery bypass grafting are effective in the prevention and treatment of CAHD, but the incidence of cardiovascular adverse events is still high. Salvia miltiorrhiza can inhibit inflammation, reduce myocardial ischemic injury, inhibit platelet aggregation and activation, improve MI area, etc. It is one of the most commonly used Chinese medicines in the treatment of chest arthralgia and heartache, and is also a common drug in the treatment of CAHD. This paper reviewed the clinical efficacy and pharmacological mechanism of salvianolate for CAHD, based on the pathogenesis of SAP, UAP and MI, in order to provide reference for clinical practice.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |